Literature DB >> 29150041

Thoracic Surgery in Early-Stage Small Cell Lung Cancer.

Matthew Low1, Sharon Ben-Or2.   

Abstract

Small cell lung cancer (SCLC) has a complex history and remains difficult to treat. Most patients with SCLC present with metastases or extensive stage disease, rendering most not amenable to surgical resection. Until recently, chemoradiotherapy had become the standard of care for all patients with SCLC. However, recent studies have shown improved survival following surgical resection with chemotherapy in patients with early-stage SCLC, specifically those with stage I disease. This article presents the literature on treatment of early-stage SCLC and addresses the question of whether surgery should be considered a viable treatment modality.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early stage; Small cell lung cancer; Surgical treatment

Mesh:

Year:  2017        PMID: 29150041     DOI: 10.1016/j.thorsurg.2017.08.003

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  5 in total

1.  CXCL4L1 May Help Differentiate Benign from Malignant Pulmonary Lesions and Predicts Prognosis of Patients with Lung Cancer.

Authors:  Lei Zhang; Guangping Li; Hongxin Zhang; Huaqun Liu; Songlin Li; Yanan Wang; Huisheng Qi
Journal:  Cancer Manag Res       Date:  2022-06-07       Impact factor: 3.602

2.  Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.

Authors:  Long Xu; Guanzhong Zhang; Shuxi Song; Zhendong Zheng
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

3.  Predictors of respiratory failure after thoracic surgery: a retrospective cohort study with comparison between lobar and sub-lobar resection.

Authors:  Aldo Pezzuto; Beatrice Trabalza Marinucci; Alberto Ricci; Massimo Ciccozzi; Giuseppe Tonini; Michela D'Ascanio; Giulio Guerrieri; Maria Chianese; Silvia Castelli; Erino Angelo Rendina
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

4.  Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer.

Authors:  Keying Che; Hongchang Shen; Xiao Qu; Zhaofei Pang; Yuanzhu Jiang; Shaorui Liu; Xudong Yang; Jiajun Du
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

5.  Using T stage and tumor thrombosis as predictive factors for patients with resected I-IIA small cell lung cancer: a retrospective study.

Authors:  Xiaowei Mao; Yiqian Ni; Yanjie Niu; Liyan Jiang
Journal:  Transl Cancer Res       Date:  2021-08       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.